Literature DB >> 27816534

Patient specific modeling of the HPA axis related to clinical diagnosis of depression.

Elisabeth O Bangsgaard1, Johnny T Ottesen2.   

Abstract

A novel model of the hypothalamic-pituitary-adrenal axis is presented. The axis is an endocrine system responsible for coping with stress and it is likely to be involved in depression. The dynamics of the system is studied and existence, uniqueness and positivity of the solution and the existence of an attracting trapping region are proved. The model is calibrated and compared to data for healthy and depressed subjects. A sensitivity analysis resulting in a set of identifiable physiological parameters is provided. A subset is selected for parameter estimation and a reduced version of the model is stated and an approximated version is discussed. The model is physiologically based, thus parameters are representative for gland functions or elimination processes. Hence the model may be used for pointing out pathologies by parameter estimation and hypothesis testing whereby it may be used as an objective and refined method for diagnosing depression and suggesting individual treatment protocols. Finally, the method may inspire pharmaceutical companies to develop target specific psychopharmaca for more effective and individual treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bio-marker; Clinical impact; Depression; HPA axis; Mathematical modeling; Non-linear ODE model; Parameter estimation; Patient specific

Mesh:

Year:  2016        PMID: 27816534     DOI: 10.1016/j.mbs.2016.10.007

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  9 in total

1.  Honokiol Exerts Antidepressant Effects in Rats Exposed to Chronic Unpredictable Mild Stress by Regulating Brain Derived Neurotrophic Factor Level and Hypothalamus-Pituitary-Adrenal Axis Activity.

Authors:  Canmao Wang; Danna Gan; Jingang Wu; Minhui Liao; Xinghuan Liao; Weipeng Ai
Journal:  Neurochem Res       Date:  2018-05-31       Impact factor: 3.996

2.  Cortisol in relation to problematic eating behaviours, adiposity and symptom profiles in Major Depressive Disorder.

Authors:  Jessica G Mills; Theresa A Larkin; Chao Deng; Susan J Thomas
Journal:  Compr Psychoneuroendocrinol       Date:  2021-06-17

3.  Applications of cosinor rhythmometry in pharmacology.

Authors:  Germaine Cornelissen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-03-23       Impact factor: 2.745

4.  Perturbing the Hypothalamic-Pituitary-Adrenal Axis: A Mathematical Model for Interpreting PTSD Assessment Tests.

Authors:  Lae Un Kim; Maria R D'Orsogna; Tom Chou
Journal:  Comput Psychiatr       Date:  2018-02-01

5.  Nesfatin-1 and cortisol: potential novel diagnostic biomarkers in moderate and severe depressive disorder.

Authors:  Ya-Yun Xu; Jin-Fang Ge; Jun Liang; Yin Cao; Feng Shan; Yang Liu; Chun-Yu Yan; Qing-Rong Xia
Journal:  Psychol Res Behav Manag       Date:  2018-10-16

6.  Understanding virtual patients efficiently and rigorously by combining machine learning with dynamical modelling.

Authors:  Tongli Zhang; John J Tyson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-01-05       Impact factor: 2.745

7.  The effectiveness of mindfulness-based cognitive therapy combined with medication therapy in preventing recurrence of major depressive disorder in convalescent patients.

Authors:  Hui-Rong Guo; Jun-Ru Wang; Ya-Li Wang; Bai-Ling Huang; Xu-Huan Yang; Yu-Ming Ren
Journal:  Front Psychol       Date:  2022-08-18

8.  A new model for the HPA axis explains dysregulation of stress hormones on the timescale of weeks.

Authors:  Omer Karin; Moriya Raz; Avichai Tendler; Alon Bar; Yael Korem Kohanim; Tomer Milo; Uri Alon
Journal:  Mol Syst Biol       Date:  2020-07       Impact factor: 11.429

Review 9.  Mathematical Modelling of Endocrine Systems.

Authors:  Eder Zavala; Kyle C A Wedgwood; Margaritis Voliotis; Joël Tabak; Francesca Spiga; Stafford L Lightman; Krasimira Tsaneva-Atanasova
Journal:  Trends Endocrinol Metab       Date:  2019-02-21       Impact factor: 12.015

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.